Today in trading, shares of Medicenna Therapeutics Corp opened at $2.55 and closed at $2.31. Intraday prices ranged from $2.30 to $2.68.

Share prices eased -7.23 percent from the previous day's close of $2.49.

Today across North America, the TSX Composite closed 0.19% at 22011.62, the S&P 500 closed 1.02% at 5099.96, the Dow Jones Industrial Average closed 0.40% at 38239.66 and the Nasdaq Composite closed 2.03% at 15927.90.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 254,395 shares was traded during the last trading day, with total trades of 404. On average, Medicenna Therapeutics Corp has traded 327,167 shares over 5 days and 137,107 year-to-date.

Trading across the entire TSX saw 3,150 price advancers against 2,056 declines and 108 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.68 (April 29,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 156.67 percent in 52 weeks, while they have risen 450.00% since the start of 2024.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $173.40 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..